Intrexon (NYSE:XON) issued its quarterly earnings data on Thursday. The biotechnology company reported ($0.33) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.24) by ($0.09), Briefing.com reports. The business had revenue of $43.80 million during the quarter, compared to the consensus estimate of $60.43 million. Intrexon had a negative return on equity of 16.94% and a negative net margin of 50.61%. The company’s revenue for the quarter was down 18.4% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.26) earnings per share.
https://bit.ly/2KTBJs0
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.